Key result
Parma ham-derived umami peptide AHSVRFY exerts antihypertensive effects via gastrointestinal bioactive peptides.
Why the study?
The antihypertensive effects of the umami peptide AHSVRFY from Parma ham and its intestinal digestion mechanisms were not fully understood.
Does the umami peptide AHSVRFY from Parma ham have antihypertensive effects in vivo?
Does the umami peptide AHSVRFY from Parma ham have antihypertensive effects in vivo?
The umami peptide AHSVRFY from Parma ham demonstrates antihypertensive effects mediated by GI-derived bioactive peptides, suggesting potential as a functional food ingredient.
molecular docking and dynamics simulations. This work shows that AHSVRFY's antihypertensive effect originates from GI-derived bioactive peptides, establishing a "digestion-activation-delivery" framework for the development of multifunctional food ingredients.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2025) studied this question. The Parma ham-derived umami peptide AHSVRFY exerts antihypertensive effects originating from gastrointestinal-derived bioactive peptides.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: